|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03692 HANSOH PHARMA
Nominal 
36.720 -0.100 (-0.272%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 8,304,007 | 11.710% | 7,433,559 | 6,505,501 | 4,511,217 | 4,434,378 |
| Cost of Sales | (671,083) | 1.558% | (660,786) | (579,218) | (535,455) | (398,582) |
| Gross Profit | 7,632,924 | 12.700% | 6,772,773 | 5,926,283 | 3,975,762 | 4,035,796 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 5,009,342 | 35.823% | 3,688,152 | 3,118,186 | 1,499,883 | 1,509,124 | |
| Taxation | (751,401) | 35.822% | (553,223) | (392,661) | (211,035) | (211,148) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 4,257,941 | 35.823% | 3,134,929 | 2,725,525 | 1,288,848 | 1,297,976 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (581,886) | 13.926% | (510,760) | (369,068) | (341,480) | (123,146) |
| Depreciation & Amortisation | 196,771 | -0.255% | 197,274 | 216,767 | 184,878 | 158,167 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 70.000 | 32.075% | 53.000 | 46.000 | 22.000 | 22.000 |
| DPS (cts) | 24.659 | -- | 21.133 | 18.347 | 6.472 | 4.377 |
| Dividend Payout Ratio (%) | 35.227% | -- | 39.873% | 39.885% | 29.418% | 19.896% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 6.228 | -- | 5.229 | 4.701 | 4.075 | 3.567 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 4,257,941 |
| %Change | 35.823% |
| EPS / (LPS) | RMB 0.700 |
| NBV Per Share (¥) | RMB 6.228 |